Skip to main content

The impact of maternal and early life malnutrition on health: a diet-microbe perspective



Early-life malnutrition may have long-lasting effects on microbe-host interactions that affect health and disease susceptibility later in life. Diet quality and quantity in conjunction with toxin and pathogen exposure are key contributors to microbe-host physiology and malnutrition. Consequently, it is important to consider both diet- and microbe-induced pathologies as well as their interactions underlying malnutrition.

Main Body

Gastrointestinal immunity and digestive function are vital to maintain a symbiotic relationship between the host and microbiota. Childhood malnutrition can be impacted by numerous factors including gestational malnutrition, early life antibiotic use, psychological stress, food allergy, hygiene, and exposure to other chemicals and pollutants. These factors can contribute to reoccurring environmental enteropathy, a condition characterized by the expansion of commensal pathobionts and environmental pathogens. Reoccurring intestinal dysfunction, particularly during the critical window of development, may be a consequence of diet-microbe interactions and may lead to life-long immune and metabolic programming and increased disease risk. We provide an overview of the some key factors implicated in the progression of malnutrition (protein, fat, carbohydrate, iron, vitamin D, and vitamin B12) and discuss the microbiota during early life that may contribute health risk later in life.


Identifying key microbe-host interactions, particularly those associated with diet and malnutrition requires well-controlled dietary studies. Furthering our understanding of diet-microbe-host interactions will help to provide better strategies during gestation and early life to promote health later in life.

Peer Review reports


Microbes of the gastrointestinal tract are associated to health and disease. It is well established that their functional coexistence within the gut can be manipulated by altering their environment, of which host nutrition has the greatest impact [1]. Although disease causality has not been directly attributed to the microbiota, researchers hypothesized that early-life exposure and assembly of microbes in the gut influences host development [2, 3]. The developmental origins of health and disease (DOHaD) hypothesis proposes that an early-life window exists where environmental exposures, including the mode of birth, nutrition, breastfeeding, infection, and antibiotics, lead to programming effects that can affect long-term health [4]. During the first 1000 days of life, host immune, endocrine, metabolic, and other developmental pathways mature in tandem with the microbiome to achieve a mutualistic relationship [5]. Even transient disturbances to microbial communities (“dysbiosis”) during this critical window of development have been associated with immune-mediated, metabolic, and neurodevelopmental disorders [6,7,8]. In this review, we discuss the potential implication of maternal and infant diet-induced microbial and host changes surrounding early-life protein, fat, carbohydrate, iron, vitamin D, and vitamin B12 malnutrition.

Contribution of microbes in health and disease

Despite mounting evidence associating the microbiota to health and disease, their causal contribution remains poorly understood. Microbes are niche-specific, meaning they are adapted to a particular lifestyle or ecological niche [9]. The microbial signature, which reflects the presence and activity of microbes, changes in response to diverse exogenous factors, including diet, disease, antibiotic usage, and host genetics [10]. For this reason, distinct microbial signatures have been identified in various human diseases, including obesity, diabetes, colorectal cancer, irritable bowel disease (IBD), liver cirrhosis, and pulmonary tuberculosis [11,12,13]. Although microbial signatures are associated with disease, it is unclear whether they are causally linked or simply a result of altered gut ecology due to metabolic and immunological changes occurring in the diseased host. Despite the fact that microbial contributions may be secondary to the causal agent of the disease, research on environmental enteropathy (EE) strongly suggests their presence is required for disease pathogenesis and indicates that microbes play a key role.

EE, also known as environmental enteric dysfunction, is a major contributor to early childhood stunting [14]. EE is a subclinical disorder associated with altered diet-microbe-host interactions and characterized by intestinal injury, nutrient malabsorption, and inflammation [15, 16]. EE can induce stunting and wasting through poor digestion and autoimmune dysfunction rather than food shortage [14]. Brown and colleagues show in a mouse model that specific bacteria are required for the development of EE [17]. Researchers were able to recreate the full effects of human EE by gavaging a defined mixture of Bacteroidales species and Escherichia coli to mice fed a protein-deficient diet (7% of the diet). However, when given an isocaloric protein-sufficient diet (20% of the diet), mice that were colonized with the same bacterial mixture did not develop EE symptoms. This suggests that both diet and microbes are necessary to induce EE.

Observations in mouse models reflect what has been observed in clinical studies, where EE symptoms are associated with both a malnourished diet and specific microbial signatures [18,19,20]. Metabolomic and proteomic analysis of blood plasma combined with metagenomic analyses of fecal samples revealed distinct microbe and host functions between healthy children and those with severe acute malnutrition when consuming the same therapeutic diet. As the children transitioned from severe to moderate acute malnutrition, their proteomic profiles became more similar to that of healthy children [19]. A microbiota-direct dietary intervention to these children had a greater impact than conventional therapy to restore microbiota structure and health [20]. Developmentally, a microbiota-direct dietary intervention increased biomarkers and mediators of growth, bone formation, neurodevelopment, and immune function towards a healthy phenotype [19]. Gnotobiotic mice and piglet models colonized with malnourished Malawian microbiota and fed a low caloric nutrient-deficient diet, resulted in weight loss and metabolic profiles distinctive of EE [18]. Kau et al. were able to show that a higher proportion of Enterobacteriaceae members relative to Akkermansia municiphila and Clostridium scindens in malnourished Malawian children was indicative of a pathogenic community related to malnutrition [21]. Using mouse models, researchers confirmed that a combination of diet and Enterobacteriaceae, Enterococcus, and Bacteroidetes members are required for EE pathogenesis.


Gastrointestinal dysbiosis is characterized by the loss of beneficial commensal microbe-host interactions and expansion of some commensal organisms, known as pathobionts, that exert pro-inflammatory effects on the host [22]. Pathobionts are opportunistic bacteria that pose a unique challenge in malnutrition research because their pathogenicity is dictated by host diet and immune function [23]. Numerous microbes have been identified as major contributors of gut dysbiosis and inflammation linked to disease, including commensal Escherichia coli strains [24], Helicobacter hepaticus [25], Bilophila wadsworthia [26], Bacteroides fragilis [27], Fusobacterium nucleatum [28], Enterococcus faecalis [29], and Akkermansia muciniphila [30]. Although diet, antibiotic, infection, and intestinal inflammation are the primary triggers of dysbiosis, pathobionts can exacerbate gastrointestinal dysfunction [22]. The impact of pathobiont overgrowth in the gastrointestinal tract on health may also be context-dependent. For example, Akkermansia muciniphila has been shown to improve glucose control [31, 32], but has also been shown to exacerbate infections and colitis [33, 34]. Reoccurring EE may be a consequence of poor diet-microbe-host interactions that limit the capacity of the gut to maintain the functional network of microbes that keep pathobionts in check.

The critical window

The critical window of development is theorized to begin during the preconception period, lasting from conception to up to the first 1000 days of life [5]. It is considered the period during development characterized by greatest phenotypic plasticity, and during which exogenous factors such as diet, antibiotics, mode of birth, and pollutants may lead to long-term physiological and immunological programming [35, 36]. The “fetal programming hypothesis” suggest that maternal nutrition and exogenous factors have long-term metabolic, immune, cardiovascular, and central nervous system effects on their offspring [37,38,39]. Moreover, the “missing microbe hypothesis” that occurs over-generations is believed to increase disease susceptibility due to suboptimal microbe-host mediated immune development. For instance, the adoption of a low-fiber diet is considered a major player responsible for the intergenerational disappearances of microbes that may promote gut stability and resiliency [40, 41]. Exogenous factors that alter early colonization and succession of microbes in the gut may delay gut maturation and development. Disruptions to microbial networks during this critical window of development are associated with asthma, allergies, diabetes, inflammatory bowel disease, and obesity [35, 42]. It is during this time that the host forms a mutualistic or immune-tolerant relationship with microbes and is thought to alter disease susceptibility (Fig. 1).

Fig. 1

The perinatal period represents a time in development when exogenous factors that affect the microbiome such as antibiotics, diet, hygiene, pathogens, mode of birth, and pollutants can alter immune and physiological programming. The effects of early-life programming may lead to increased disease susceptibility later in life. Created with


As stated in the UN Millennium Development Goals, the supply of potable water and proper sanitation to control gastroenteritis and malnutrition are important targets across the globe. Intervention trials in these areas, also referred to as WASH (water supply, sanitation, and hygiene), involve the provision of water quality at a public or household level, improved means of excreta disposal, health, and hygiene education, and promotion of handwashing. It has been suggested that EE is a contributor to malnutrition and growth delay in children living in areas with poor sanitation. A systematic review by Gera et al. of trials conducted over the past 10 years in developing countries [43] documented a modest effect of WASH interventions on most anthropometric parameters and studies were of low-quality evidence. Improvement in water quality was associated with a slightly higher weight-for-age Z-score (p = 0.06). Combined water, sanitation, and hygiene intervention improved height-for-age Z-scores (MD 0.22; 95% CI 0.12, 0.32) and decreased the risk of stunting (RR 0.87; 95% CI 0.81, 0.94). Several ongoing trials on these interventions may improve the quality of evidence on infant malnutrition. In a more recent trial of WASH and de-worming in Timor-Leste [44], a trend was observed for a reduction in levels in young children of the fecal EE biomarker, myeloperoxidase; this finding was statistically significant when household water was stored in covered containers.

On the other hand, improved hygiene through regular use of household cleaning products in developed countries has had unintended consequences on infant growth. Despite their widespread use since the late 20th century, antimicrobial cleaning products have not always reduced infection rates of household members, and they release chemicals into the indoor environment [45]. Based on data from full-term infants in the Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort, it was found that infant exposure to frequent cleaning with household disinfectants was associated with altered gut microbial composition at age 3–4 months and risk of being overweight by age 3 [46]. The main attribute of hygiene on malnutrition is immune and gut maturation, where excessive hygiene may hamper symbiont colonization and too little may increase pathogen load.

The diet-microbe link

As in many cases, there is a constant struggle between cause and effect with respect to microbial dysbiosis and disease outcome in the study of malnutrition and the microbiome. Although the debate to what effect the microbiota contributes to disease remains unclear, it is reasonable to conclude that both gut microbes and environment contribute to the pathogenesis of malnutrition and undernutrition (Fig. 2). Dietary components play a major role in maintaining microbe-host interactions that may promote intestinal health [47]. Therefore, nutrition is an important tool that can be manipulated to restore beneficial microbe-host interactions that enhance intestinal integrity and health.

Fig. 2

Diet is a major contributor to the pathology of malnutrition and undernutrition. Nutrient quality and quantity can alter host immunity directly and through alteration of gut microbial communities. Dysbiosis adds to the cycle of malnutrition through dietary fermentation by-products, pathobiont overgrowth, and epithelial oxygenation. These conditions alter intestinal permeability, leading to increased pathogen susceptibility and endotoxemia that hampers host immunity and increases disease susceptibility. Created with


Beginning in the 1950s, protein-energy malnutrition (PEM) became a primary focus associated with stunting and disease susceptibility in children from developing countries [48]. Food shortage is the main culprit of PEM and is estimated to affect 1 in 4 children under the age of 5 worldwide [49, 50]. The prevalence of stunting and wasting, particularly in developing countries, is attributed to low protein-energy intake and increased exposure to enteric infections as a result of poor sanitation [51]. The “protein gap” was considered the primary reason for PEM; however, after much debate, children in developing countries were actually estimated to consume adequate protein, even above recommended levels [48, 52]. The prevalence of stunting could not be explained by protein intake alone and instead has been attributed to intestinal dysfunction and poor energy density from weaning food in developing countries [49, 52]. Unabsorbed proteins can alter intestinal dynamics directly by disrupting gastrointestinal enzymes, receptors, or other activities [53]. Indirectly, protein malabsorption in the small intestine can lead to microbial proteolytic fermentation by-products (H2, CO2, CH4, H2S, short-chain fatty acids (SCFAs), branched chain amino acids (BCAAs), nitrogenous compounds, phenols, and indoles) in the colon with poorly understood health outcomes [54, 55]. Using national level data collected from 180 countries, Ghosh and colleagues concluded that dietary utilizable protein provides a better index of protein inadequacies than total crude protein intake alone [56]. An individual’s protein requirement should be based on protein quality and digestibility, along with the burden of infection and energy deficits of the individual [48, 56]. In addition, microbe-host interactions directed by dietary proteins can provide further insight to assess protein quality and requirements that optimize intestinal health, especially during early development.

Protein-insufficient diet models are used to study the effects of protein malnourishment on intestinal health [17, 57]. Reducing dietary protein in mice from 20 to 5% has drastic consequences on growth stunting, intestinal permeability, and immune function resulting in intestinal inflammation with features similar to EE in humans [17]. Dietary protein provides essential amino acids for protein synthesis, as well as is important for satiety, glucose, and lipid metabolism, blood pressure, bone metabolism, and immune function [53]. Studies show a unique microbial signature specific to protein-deficient diets, distinguished by an increase in Bacteroidetes and Proteobacteria species, and a decrease in Lactobacillaceae and Erysipelotrichaceae in the gastrointestinal tract [17, 57]. A decrease in Lactobacillaceae and Erysipelotrichaceae family members are associated with intestinal integrity dysfunction, inflammation, and increased susceptibility to enteric pathogens in mice [58, 59]. Similarly in humans, the population of Bacteroidetes and Proteobacteria species has been shown to be high, while Lactobacillaceae species stay low as assessed in a Malawian twin study that evaluated kwashiorkor disease [18]. Early-life protein restriction post-weaning in mice led to temporary glucose intolerance following nutritional recovery but did not increase susceptibility to diet-induced liver steatosis and insulin resistance later in life [60]. A critical window may exist during gestation and suckling prior to weaning that this study did not include and may explain the transient metabolic dysfunction associated from post-weaning dietary protein deficits.

Aside from the microbiota, there is evidence suggesting that maternal protein consumption can impact the metabolism and immune system of their offspring. A high-protein maternal diet was able to stimulate hypothalamic MAPK insulin signaling pathways that are involved in controlling energy and nutrient homeostasis [61]. A diet low in protein was determined to activate the liver and hypothalamus hedgehog-signaling pathway that is positively correlated with liver disease (e.g., NAFLD) and hepatic repair mechanisms [61]. A low-protein diet during pregnancy and lactation leads to increased inflammatory status as determined by the expression of microRNAs (miRNAs), and levels of inflammatory IL-6 and TNF-α markers in mice [37]. miRNAs are shown to be involved in the pathogenesis of metabolic disorders by regulating insulin signaling, immune-mediated inflammation, adipokine expression, adipogenesis, lipid metabolism, and food intake [62]. In pigs, a low-protein diet increased cortisol and decreased protein levels in sows, and led to high cortisol, low IgA, and increased mortality in suckling piglets [63]. The high-protein diet decreased systemic immunoglobulin (IgA, IgG, and IgM) and increased systemic CD4+ lymphocytes and CD4+/CD8+ ratio in weaned piglets indicating altered immune function. An optimal quantity of dietary protein may exist because both low- and high-protein diets increased IL-6 in the blood of piglets challenged with lipopolysaccharide (LPS) compared to normal protein feeding [63]. Maternal high-protein (40% of diet) diets during pregnancy, but not lactation, alter hepatic gene expression in adult mouse offspring, suggesting permanent imprinting on metabolic function [64]. A small number of genes persisted in adulthood, including those involved in liver regulation, damage, and metabolic dysfunction (Hifla and Hnf4a), and genes that regulate liver DNA methylation (Mecp2 and Sin3a) that explain the long-term imprinting effects of a prenatal high-protein diet [64]. Moreover, glucagon-like protein-1 (GLP1) was higher in high-protein offspring (protein induces satiety) and was associated with reduced insulin sensitivity as determined by high insulin serum levels and increased resistin and IL-6 expression in brown adipose tissue in rats [65]. Rat offspring from dams given a high-protein diet during gestation had a 41.2% increase in adiposity correlating with a significantly increased phosphoenolpyruvate carboxykinase (PEPCK; a gluconeogenesis enzyme) and altered insulin signaling compared to normal protein maternal diets [66]. A high-protein diet during gestation and lactation is shown to increase plasma insulin when rat pups are weaned on a normal protein diet; however, weight gain remained the same between groups [67]. This research indicates that maternal and infant protein consumption may contribute to metabolic programming lasting into adulthood. Yet, the discrepancy between some studies linking high-maternal-protein diets to offspring weight gain may indicate a role of the gut microbiota and requires further investigation.

The amount of protein consumed early in life may play an important role in programing metabolic function. Although the mechanism of programming is poorly defined, the effects of dietary protein may have a microbial component. The “early protein hypothesis” suggests that the consumption of a high-protein diet with sufficient energy, such as the typical infant formula, increases infant weight gain, adipogenic activity, and obesity risk later in life [68]. During the first 6 months of life, protein intake has been shown to be 66–70% higher in formula-fed (FF) than in breastfed (BF) infants leading to greater weight gains in infants from 3 to 9 months [69]. This is partly due to the fact that infant formula contains higher concentrations of protein than human breast milk. Protein content of human breast milk ranges from 1.4–1.6 g/100 mL to 0.8–1.0 g/100 mL after 4 months of lactation, whereas infant formula ranges from 2 to 3.5 g/100 mL, with a higher protein formula given to low birth weight or preterm infants [70]. In a multicenter, double-blind, randomized clinical trial, high-protein FF infants (6 years old) had a significantly higher body mass index (BMI) and were twice as likely to develop obesity compared to the low-protein FF infants [71]. Limiting protein intake may help reduce the effects of long-term metabolic programming; however, the events leading to this observation and cause are still poorly understood. A targeted serum metabolome analysis revealed BF infants demonstrated increased fat metabolism, whereas FF infants had a metabolite profile indicative of protein metabolism [72]. The greatest difference was determined at 2 months (baseline), 4 months, and 6 months of age, and remained different when “carbohydrate-rich” complementary foods were added to the diet. Fecal microbiome structure and metabolomic profile mirrored changes associated with serum metabolite profiles [72, 73]. As expected, protein-rich infant formula induced microbial end-products typical of peptide and amino acid fermentation such as branched chain fatty acids (BCFAs; isobutyrate and isovalerate) and phenylacetate [73]. The contribution of the microbiota to the relationship between early-life protein and long-term metabolic outcomes has not been explored in a controlled system; however, given the evidence linking early-life microbial disruptions with long-term disease risk supports a role of protein-microbe interactions.

Excessive protein intake can lead to protein fermentation products known to disrupt gastrointestinal tract function and contribute to the pathogenesis of irritable bowel syndrome and ulcerative colitis, with a distinguishing malodorous flatus [54]. Plant-based diets from developing countries such as bean and cowpea flour are primarily poor in protein quality and reduced linear growth compared to fish protein-rich diets [74]. Maize and cassava are other popular protein sources in developing countries that are poor sources of tryptophan and lysine [75]. Microbiota-derived tryptophan metabolites are instrumental in maintaining intestinal homeostasis [76]. In fact, tryptophan is considered the limiting amino acid in infant formula (~ 250 mg/L) due to low bioavailability from bovine milk protein. Formula would require twice as much tryptophan to reach the bioavailable levels similar to that of breast milk (~ 200–400 mg/L) [72]. Processes that disrupt microbial activity and reduce tryptophan metabolite capacity can lead to increased digestive dysfunction and pathogen susceptibility [77, 78]. In mice, dietary amino acid metabolism has been mechanistically linked to angiotensin I-converting enzyme 2 (Ace2) deficiency by altering microbial gut ecology and antimicrobial peptide expression, increasing infection susceptibility [79]. Bioavailability of certain amino acids may play an instrumental role in diet-induced dysfunctions leading to PEM. Protein source and digestibility can impact microbe-host interactions in the gut, perpetuating malnutrition by decreasing intestinal integrity and function [47]. More research is needed to determine to what extent the microbiota and host intestinal activities are programmed through maternal exposure to the amount and source of proteins.


A universal deficiency that occurs in malnutrition, both energy and PEM, is a less than sufficient intake of fat and/or essential polyunsaturated fatty acids. Although the gut microbiota is recognized as an important pathophysiologic factor in the development and sustainment of malnutrition, there are few studies that have specifically examined their impact in relation to dietary fat. It is, however, generally accepted that the bidirectional interactions between the microbiome, fat availability, and gastrointestinal function contribute to a vicious circle, further impairing health outcome in malnutrition [80].

Although gut microbes have been implicated in regulating fat absorption and metabolism [81], a comprehensive and mechanistic approach to understanding the pathways is still needed. In a healthy infant, > 95% of fats are absorbed before entering the large intestine. Malnutrition, especially in infants/children results in a generalized disturbance of the small intestine structure (shortened, blunted villi, and increased crypt depth) and function (disturbances in permeability and absorption) resulting in fat malabsorption [80]. This results in diarrhea, weight loss, other nutritional deficiencies, and gut dysbiosis [80]. The accompanying intestinal and systemic inflammation are suggested to contribute to these pathological changes [80, 82]. Additionally, the microbiota plays a major role in bile acid deconjugation [83]. Altered microbial deconjugation of bile acids would further impair absorption of fat, cause bile salt injury to the colon, and interfere with digestive enzymes and nutrient transporters [80].

In the colon, microbial perturbations can indirectly alter energy balance via changes in the levels of anorectic hormones (peptide YY (PYY) and GLP-1) and effects on energy (both lipid and glucose) metabolism [84]. The gut microbiota has been demonstrated to stimulate hepatic triglyceride production (lipogenesis) by activating the transcription factors, carbohydrate response element binding protein (ChREBP), and sterol response element binding protein (SREBP) [85]. Recently, a critical role of the, complex but less diverse, small intestine microbiota as a regulator of fat digestion and absorption has been identified [86, 87]. These microbes appear to be essential for host adaptation to dietary lipid changes by regulating gut epithelial processes involved in their digestion and absorption. It is hypothesized that this occurs via systemic control of enteroendocrine signaling and an effect on erythrocytes fatty acid transport [87]. As fat is the major energy source for infants and children, an inadequate supply can lead to long-term health consequences to the infant/child through the impact on inadequate energy reserve, epigenetic changes in cells critical for growth, long-term defects in the small intestine and immune maturation, and recurrent bouts of infection [82]. Changes to the microbiome early in life could also have lasting effects on the ability to adapt to changes in fat intake later in life, thereby contributing to metabolic disorders [87].

A supply of both the n-6 and n-3 PUFA is essential for growth and intestinal, neurocognitive, visual, and immune development [88, 89]. Among the n-3 PUFA, eicosapentaenoic acid (EPA; C20:5) and docosahexaenoic acid (DHA, C22:6) are the two main bioactive forms in humans and for the n-6, arachidonic acid (Ara, C20:4). An n-3 PUFA deficiency, especially during intrauterine and early life, is associated with impaired psychomotor development, and issues with attention, cognition, and visual acuity [90]. An insufficient supply of PUFA alters systemic and intestinal immune development, which occurs postnatally within the first 3 years of life [89]. However, the development of the immune system is closely tied with that of the microbiome [85]. Despite this knowledge, the impact of essential fatty acid deficiency on the microbiome has not been well studied.

Studies have shown that different types of dietary fat, including saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and PUFAs, and their abundance in the diet, could change gut microbiota composition [91]. There is growing evidence for a potential role of a disrupted microbiota in metabolic disorders induced by n-3 PUFA deficiency. Studies have shown that dietary n-3 PUFAs can modify the intestinal microbiota composition by increasing the number of bifidobacteria that decrease gut permeability and decreasing the number of Enterobacteria that increase intestinal permeability [92]. Animal studies have reported that supplementation of n-3 PUFA in young rodents can restore the disturbed gut microbiota composition of maternally separated female rats [93] or the disrupted function of the microbiome in male pups [90]. The position of the DHA or ARA in milk triacylglycerols has also been demonstrated to modify the intestinal bacterial population of the suckling rodent [94]. The effect of these fats on the microbiota is best explained by indirect mechanisms. This is particularly evident in a study that demonstrated differences in microbial composition in response to changes in the parenteral fatty acid formulations [95].

The impact of PUFA on the gut microbiota is less well defined. The few studies completed in adults showed some common changes in the gut microbiota after n-3 PUFA supplementation. In particular, a decrease in Faecalibacterium, often associated with an increase in the Bacteroidetes and butyrate-producing bacteria [92]. Although the literature on this topic is discordant, n-3 PUFAs are generally associated with anti-inflammatory effects, in comparison with the omega-6 PUFAs that are linked to pro-inflammatory effects, due to the different downstream lipid metabolites [92]. Supplementation with n-3 PUFAs can exert a positive action by reverting the microbiota composition in adult inflammatory diseases and increase the production of anti-inflammatory compounds, like short-chain fatty acids [92]. In addition, accumulating evidence in animal model studies indicates that the interplay between gut microbiota, n-3 PUFA, and immunity helps to maintain intestinal integrity and influences the gut–brain axis, acting through shifts in the microbial gut network [92]. Infant trials have demonstrated that supplementation with PUFA results in greater bacterial diversity combined with lower abundance of some pathogenic bacteria, such as Streptococcus, Clostridium, and some genera of the Enterobacteriaceae family, such as Escherichia, Klebsiella, Serratia, and Citrobacter, suggesting that n-3 PUFAs favor the butyrate-producing bacterial genera [96]. Identifying direct and indirect attributes of dietary fats on microbial networks and immune function will help elucidate the contribution of dietary fat type and quantity on malnutrition status.


The main contribution of carbohydrate in human nutrition is to provide glucose for supporting the high energy demands of the brain and muscular system [97, 98]. Experts recommend an intake of 150 g/day in adults to support muscle and brain physiology, but no minimum requirement has been established [99, 100]. Humans have thrived on diets containing various amounts and types of carbohydrates. However, the excessive consumption and reliance on poor-quality carbohydrates is thought to have contributed to the increased prevalence of chronic diseases [100]. Although difficult to define, the nutritional quality of a carbohydrate can be described by their digestibility and activity on the microbiota.

Unabsorbed carbohydrates are fermented by gut bacteria into lactic acid, succinate, SCFAs (acetate, propionate, and butyrate), and hydrogen, methane, and carbon dioxide gases [101]. SCFAs are associated with improved intestinal and metabolic health; however, it may also contribute to a variety of gastrointestinal symptoms including abdominal cramps, bloating, flatulence, and diarrhea [102]. Carbohydrate malabsorption is frequently reported in severely malnourished children; however, to what extent it contributes to the pathologies surrounding malnutrition remains unclear [103]. Population-based studies that followed the introduction of refined carbohydrates to the diet have shown an increased prevalence of atherosclerotic disease, coronary heart disease, and diabetes [104, 105]. The risks associated with diets high in simple sugars (e.g., sucrose, glucose, fructose) is considered a result of impaired intestinal permeability due increased LPS endotoxemia and loss of luminal SCFAs [106, 107]. Although a strong link exists between a high simple sugar diet and poor health outcomes, research suggests that dietary fiber and resistant starches may be more important than quantity and glycemic load of simple carbohydrates [108].

Dietary fiber and resistant starch are complex polysaccharides that support homeostasis through their effects on the intestinal mobility and microbiota. The recommended adequate intake of dietary fiber is 14 g/1000 kcal, equating to approximately 28–36 g/day in human adults, a number that many experts believe should be closer to 50 g/day [109, 110]. The bulking properties of dietary fiber are well known to positively influence gastric emptying, fecal frequency, and satiety [111]. The production of SCFAs, specially butyrate, provides direct energy to gut epithelial cells and promotes intestinal homeostasis by maintaining a hypoxic environment, mucus production, and antimicrobial peptide secretion [112,113,114,115,116]. Commonly known as prebiotics or microbial-accessible carbohydrates (MACs), fibers and starches that encourage SCFA production also promote microbial diversity and resiliency. In mouse models, these attributes have consistently supported the positive effect of MACs on intestinal integrity [117, 118]. A MAC-deficient diet is hypothesized to have contributed to gut microbe extinctions across generations, leading to reduced diversity and SCFA production, and dysbiosis associated to disease later in life [5, 41]. The type and quantity of MACs directly alters microbial gut networks and fermentation products, such as SCFAs, wherein effects on host physiology and health have been exhaustively reviewed [109, 118, 119]. To what extent dietary MACs shape early-life development and disease risk remains unknown and requires well-controlled studies comparing MAC type and introduction to the diet during the critical window of development.


Iron deficiency (ID) is the most common nutritional deficiency in the world and is highly prevalent in both developed and developing nations. The sub-populations most at risk of ID, irrespective of geographical location, are pregnant women and young children [120]. The world health organization (WHO) estimates that 38% of all pregnant women (~ 496 million worldwide) and 43% of children (~ 273 million worldwide) are anemic [121], of which more than half are attributed to ID [120]. Early childhood is characterized by increased demands for iron, which is needed to support tissue and organ development as well as blood volume expansion. Consequently, reduced iron availability (due to inadequate intake or absorption, chronic inflammation, or insufficient iron accretion and storage in gestation) during this critical period can lead to suboptimal growth, with potential consequences for long-term health. Indeed, epidemiological studies show ID in childhood is associated long-lasting deficits in cognitive ability, memory, and executive function [122,123,124,125]. Studies in rats show that maternal iron restriction in pregnancy and consequent ID in offspring affects growth and developmental trajectories, with lasting effects on behavior and cognition [126], and cardiovascular and metabolic health [127,128,129,130,131].

The mechanisms by which ID impacts offspring development are complex and likely depend on the organ system in question, but pathophysiological processes including hypoxia [132], altered energy metabolism, reactive oxygen species generation [133], epigenetic changes [134, 135], and altered neurotransmitter and hormonal profiles [136,137,138] are implicated. More recently, the profound modulatory effects of iron availability on gut microbiome composition and function have been demonstrated [139, 140], with implications for metabolic substrate production [139, 140] and risk of infection by enteropathogens in young children with ID. Indeed, just as iron is essential for eukaryotic cell function, most bacterial species depend on iron for survival and pathogenicity [141,142,143], and as such, availability of iron may play an important role in microbiome niche selection.

In young children, ID anemia was associated with increased enterobacteria and Veillonellaceae, reduced Coriobacteriaceae, and reduced the bifidobacteria/enterobacteria ratio [144]. A study by McLorry et al. also showed that anemia in boys and girls was associated with lower levels of butyrate-producing bacteria (Butyricicoccus in females, Coproroccus and Roseburia in males) [145]. In general, these reports are consistent with in vitro studies using a continuous gut fermentation model inoculated with child gut microbiota [139, 140]. In these experiments, Dostal et al. reported that low iron conditions reduced butyrate-producing bacteria (e.g., Roseburia spp., Eubacteria rectale, Clostridium cluster IV members, and Bacterioides spp.) and reduced butyrate concentrations and other SCFA (acetate and propionate) [139, 140], and these effects could be reversed with provision of iron [139]. The authors also recapitulated these trends in vivo in weaning rats [146].

However, the influence of iron status on microbial composition and function in children is complicated by several population factors, including enteropathogen exposure (e.g., high vs. low pathogen burden [147]), anemia identification with and without iron deficiency, dietary fortification regimens, and use of iron supplements. The latter is particularly notable, because iron supplementation is routinely implemented in populations at risk of ID, including young children [148]. In excess, unabsorbed iron remains in the gastrointestinal tract, where it may provide a labile iron pool for bacteria. Notably, several species of Proteobacteria (e.g., Enterobateriaceae such as Escherichia coli and Salmonella) and Firmicutes (Bacillus) require iron to colonize and persist in the intestine [149]. In an iron-rich colonic environment, such as that produced by excess iron supplementation, Proteobacteria may thrive at the expense of other gut bacteria [150, 151]. Consistent with this idea, studies show that supplementation with iron supplements and iron-rich micronutrient powders can increase diarrhea risk, which may be mediated by increased abundance of Enterobacteria (including E. coli) and reduced abundance of beneficial commensal bacteria (e.g., bifidobacteria, lactobacilli) [152,153,154]. The risks and benefits of iron supplements and micronutrient powders in children, particularly in low- and middle-income countries, is an active area of research, and several excellent reviews on the topic are currently available [148, 155].

It is interesting that ID anemia, which is presumably associated with reduced iron availability in the gut, is associated with increased abundance of Enterobacteria (as discussed above), given the iron requirements for colonization and virulence. However, many members of this group are known to use siderophores, high-affinity compounds that bind and sequester iron, and other specialized iron transport systems which enable these bacteria to effectively compete for iron when availability is scarce [141]. In their study, Dostal et al. showed that the abundance of Enterobacteriaceae increased with low iron, but decreased with provision of FeSO4 [146]; the latter finding may reflect a loss of this competitive advantage with increasing iron availability, and the reduced growth may be secondary to growth promotion of other bacterial groups (e.g., Allobaculum spp.). Notwithstanding, these studies highlight a complex but important interrelationship between the microbiota in childhood and iron status, and highlight a myriad of influences on this relationship, including use of iron supplements and their formulations, population characteristics, presence of other nutritional deficiencies, or excesses among others.

Vitamin D

Vitamin D is a fat-soluble vitamin with many molecular forms. A paper by Mokhtar and colleagues on vitamin D status and growth in Ecuadorian children is an important contribution [156]. Mean serum 25(OH)D levels did not differ between underweight (WAZ < − 1.0) and non-underweight children, although underweight children were twice more likely to have serum vitamin D levels < 42.5 nmol/L. In order for vitamin D to elicit a physiological response, it must be converted in the liver and kidney to its active form, calcitriol (1,25(OH)2D3), but it must also bind with the nuclear vitamin D receptor (VDR) [157]. VDR is highly expressed in the proximal colon and acts as a transcription factor responsible over 1000 genes, including the defensins, cathelicidin, claudins, TLR2, zonulin occludens, and NOD2 [158, 159]. These proteins are major drivers of inflammation; they help with the maintenance of the host barrier and promote tolerance to cytokines and the gut microbiota. Given the role of VDR and downstream regulators of microbe-host interactions, it is worthwhile considering the evidence on interactions between vitamin D and gut microbiota in early life, especially in view of the important role of infant gut microbiota in child weight gain [160].

A recent systematic review provides up-to-date information regarding vitamin D and the gut microbiota in animal, cell, and human studies [161]. In animal studies which typically use VDR KO (knock-out) mice, microbial “dysbiosis” has been reported, characterized by a greater abundance of Proteobacteria, Bacteroides spp. and Clostridium spp. [162, 163]. Few studies have been published in human adults. In a cross-sectional analysis of 150 healthy adults, Luthold and colleagues found higher levels of serum 25(OH)D to be associated with greater abundance of Bifidobacterium and Prevotella in gut microbiota but a depletion in Haemophilus and Veillonella [164]. Stool samples and biopsies obtained from the gastrointestinal tract of 15 healthy adults taken before and after supplementation with high doses of vitamin D3 showed higher microbial richness and enrichment with Proteobacteria in biopsies; no significant changes to the microbial composition in stool samples [165]. Finally, human adults who are deemed to have an “insufficient” serum vitamin D level have two times greater odds of acquiring Clostridium difficile infections at hospitalization, compared to patients who are vitamin D deficient [166].

The evidence in human infants is even more sparse. The KOALA birth cohort study examining both maternal and infant vitamin D supplementation found that infant direct supplementation (i.e., via liquid drops) did not alter gut microbial composition at 1 month after birth [167]. However, indirect vitamin D exposure, specifically maternal prenatal multivitamin supplementation, was correlated with greater abundance of Bacteroides fragilis and reduced presence of Bifidobacterium spp. and C. difficile. In the Vitamin D Antenatal Asthma Reduction (VDAART) Trial, mothers of infants received either 4000 IU vitamin D plus prenatal vitamins or 400 IU vitamin D plus prenatal vitamins during the first trimester of pregnancy [168]. There were no observed differences between the diversity of microbiota in the two exposure groups at 3–6 months of age. However, enrichment with Lachnospiraceae and Lachnobacterium and depletion of Lactococcus were observed in infants with higher vitamin D levels in cord blood.

Maintaining adequate vitamin D levels is crucial for vitamin D-dependent immunity and physiology, which is particularly important during growth and development. Increasing vitamin D status through nutrition, supplementation, or sun exposure will modulate the gastrointestinal microbiota by supporting the gut environment and normalizing autoimmune responses [169]. Although vitamin D can be treated with supplementation and increased sunlight exposure, genetic factors, malabsorption (i.e., EE), and underlying conditions, such as cystic fibrosis, celiac disease, and IBD, can lead to deficiencies [170]. Future studies should focus to delineate between host physiological and immune changes surrounding vitamin D status that may alter the gastrointestinal environment and the succession of microbes to children from vitamin D-deprived mothers at birth.

Vitamin B12

Vitamin B12, also known as cobalamin, is a water soluble cobalt-containing vitamin that is exclusively synthesized by bacteria and archaea [171]. In humans, it is essential for DNA synthesis, cellular energy production, red blood cell maturation, and myelin synthesis of neural networks. Inadequate absorption of cobalamin from diet leads to anemia and neurologic dysfunction [172]. In malnourished children, vitamin B12 deficiency is more common than folate and iron deficiency and can lead to long-term brain damage [173, 174]. Insufficient vitamin B12 status has been shown to lower cognitive development and performance [175], cause growth and motor retardation [176], and decrease bone mass in children [177].

Many gut bacteria encode for multiple vitamin B12 transporters, while less than 25% are predicted to synthesize it [178]. Because endogenous bacterial production of vitamin B12 occurs in the colon, it is unlikely to significantly contribute to host B12 status. Enterohepatic circulation and microbial remodeling contribute to a pool of at least eight distinct vitamin B12-derivatives (corrinoids) identified in human feces [179]. The presence of multiple corrinoids, corrinoid microbial transporters, and corrinoid-dependent enzymes suggest competition exists between gut bacteria. Research has focused to identify the ability of vitamin B12 to modulate gut microbial ecology and how these interactions influence disease status [180].

Vitamin B12 derivatives are involved in syntrophic microbe-microbe interactions in the gut that help maintain symbiosis and intestinal health [180]. For instance, in vitro co-culture studies suggest Akkermansia muciniphila, a mucus-degrading microbe associated with a lean phenotype and enhanced barrier function, may rely on Eubacterium hallii to provide them with corrinoids [181]. Competition between gut bacteria for corrinoids occurs when resources are limited or when an increased demand is required [182]. Research has shown that commensal Bacteroides thetaiotaomicron is able to outcompete enterohemorrhagic E. coli (EHEC) for vitamin B12 via cell surface-exposed lipoproteins [183]. Furthermore, mutant B. thetaiotaomicron lacking B12 transporters lose their ability to inhibit EHEC virulence factors [184]. In excess through supplementation, vitamin B12 availability may increase the risk of enteric pathogens in the gut. This is especially important in regions of poor socioeconomically status, where risk of enteric infection is high. Deficiencies treated with supplements in excess can help to restore vitamin B12 status but may also support enteric pathogen fitness contributing to EE and worsening malnutrition status. Future research should focus on the effects of dietary vitamin B12 on microbial gut ecology and intestinal health.


Controlling the microbiota with targeted dietary interventions, particularly in cases of malnutrition, may prove to be a vital therapeutic option in preventative healthcare. The mounting concerns over early-life nutrition have pointed towards the microbiota and disruptive gut function as a causal factor towards disease susceptibility later in life; however, the direct cause and effect are difficult to tease out. Future nutritional research will require well-controlled studies of a nutrient on its own and in combination with other components that stress and protect the gut. Using an omics and an extensive host phenotyping approach will help unravel the complex interactions between the gut microbiota and health of malnourished children.



Developmental origins of health and disease


Irritable bowel disease


Environmental enteropathy


Water supply, sanitation and hygiene


Canadian Healthy Infant Longitudinal Development


Protein-energy malnutrition


Short-chain fatty acids


Branched chain amino acids


Mitogen-activated protein kinase


Nonalcoholic fatty liver disease






Peptide YY


Glucagon-like protein-1


Phosphoenolpyruvate carboxykinase






Branched chain fatty acids


Angiotensin I converting enzyme 2


Carbohydrate response element binding protein


Sterol response element binding protein


Polyunsaturated fatty acid


Eicosapentaenoic acid


Docosahexaenoic acid


Saturated fatty acids


Monounsaturated fatty acids


Arachidonic acid


Microbial-accessible carbohydrates


Iron deficiency


World Health Organization


Vitamin D receptor




Enterohemorrhagic Escherichia coli


  1. 1.

    Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15:73.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med. 2016;22:713–22.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Arrieta M, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B. The intestinal microbiome in early life: health and disease. Front Immunol. 2014;5(September):427.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Stiemsma LT, Michels KB. The role of the microbiome in the developmental origins of health and disease. Pediatrics. 2018;141.

  5. 5.

    Robertson RC, Manges AR, Finlay BB, Prendergast AJ. The human microbiome and child growth - first 1000 days and beyond. Trends Microbiol. 2019;27:131–47.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Arrieta M-C, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7:307ra152.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158:705–21.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Gur TL, Shay L, Palkar AV, Fisher S, Varaljay VA, Dowd S, et al. Prenatal stress affects placental cytokines and neurotrophins, commensal microbes, and anxiety-like behavior in adult female offspring. Brain Behav Immun. 2017;64:50–8.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Dutta C, Paul S. Microbial lifestyle and genome signatures. Curr Genomics. 2012;13:153–62.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Kho ZY, Lal SK. The human gut microbiome - a potential controller of wellness and disease. Front Microbiol. 2018;9(AUG):1835.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Armour CR, Nayfach S, Pollard KS, Sharpton TJ. A metagenomic meta-analysis reveals functional signatures of health and diesease in the human gut microbiome. mSystems. 2019;4:1–15.

    Article  Google Scholar 

  12. 12.

    Hu Y, Feng Y, Wu J, Liu F, Zhang Z, Hao Y, et al. The gut microbiome signatures discriminate healthy from pulmonary tuberculosis patients. Front Cell Infect Microbiol. 2019;9:90.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Caussy C, Tripathi A, Humphrey G, Bassirian S, Singh S, Faulkner C, et al. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat Commun. 2019;10:1406.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Budge S, Parker AH, Hutchings PT, Garbutt C. Environmental enteric dysfunction and child stunting. Nutr Rev. 2019;77:240–53.

    Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Bartelt LA, Bolick DT, Guerrant RL. Disentangling microbial mediators of malnutrition: modeling environmental enteric dysfunction. Cell Mol Gastroenterol Hepatol. 2019;7:692–707.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Gómez-Gallego C, García-Mantrana I, Martínez-Costa C, Salminen S, Isolauri E, Collado MC. The microbiota and malnutrition: impact of nutritional status during early life. Annu Rev Nutr. 2019;39:267–90.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Brown EM, Wlodarska M, Willing BP, Vonaesch P, Han J, Reynolds LA, et al. Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat Commun. 2015;6:7806.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013;339:548–54.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Gehrig JL, Venkatesh S, Chang H, Hibberd MC, Kung VL, Cheng J, et al. Effects of microbiota-directed foods in gnotobiotic animals and undernourished children. Science. 2019;365.

  20. 20.

    Raman AS, Gehrig JL, Venkatesh S, Chang H, Hibberd MC, Subramanian S, et al. A sparse covarying unit that describes healthy and impaired human gut microbiota development. Science. 2019;365.

  21. 21.

    Kau AL, Planer JD, Liu J, Rao S, Yatsunenko T, Trehan I, et al. Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy. Sci Transl Med. 2015;7:276ra24.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Zechner EL. Inflammatory disease caused by intestinal pathobionts. Curr Opin Microbiol. 2017;35:64–9.

    Article  PubMed  Google Scholar 

  23. 23.

    King SJ, McCole DF. Epithelial-microbial diplomacy: escalating border tensions drive inflammation in inflammatory bowel disease. Intest Res. 2019;17:177–91.

    Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Kittana H, Gomes-Neto JC, Heck K, Geis AL, Segura Muñoz RR, Cody LA, et al. Commensal Escherichia coli Strains Can Promote Intestinal Inflammation via Differential Interleukin-6 Production. Front Immunol. 2018;9(OCT):2318.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Chow J, Mazmanian SK. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe. 2010;7:265–76.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Feng Z, Long W, Hao B, Ding D, Ma X, Zhao L, et al. A human stool-derived Bilophila wadsworthia strain caused systemic inflammation in specificpathogen-free mice. Gut Pathog. 2017;9:59.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Sears CL, Geis AL, Housseau F. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J Clin Invest. 2014;124:4166–72.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Han YW. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol. 2015;23:141–7.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    de Almeida CV, Taddei A, Amedei A. The controversial role of Enterococcus faecalis in colorectal cancer. Ther Adv Gastroenterol. 2018;11:1756284818783606.

    Article  Google Scholar 

  30. 30.

    Nobel YR, Cox LM, Kirigin FF, Bokulich NA, Yamanishi S, Teitler I, et al. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat Commun. 2015;6(May):7486.

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426–36.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Derrien M, Belzer C, de Vos WM. Akkermansia muciniphila and its role in regulating host functions. Microb Pathog. 2017;106:171–81.

    Article  PubMed  Google Scholar 

  33. 33.

    Seregin SS, Golovchenko N, Schaf B, Chen J, Pudlo NA, Mitchell J, et al. NLRP6 protects Il10-/- mice from colitis by limiting colonization of Akkermansia muciniphila. Cell Rep. 2017;19:733–45.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Ganesh BP, Klopfleisch R, Loh G, Blaut M. Commensal Akkermansia muciniphila exacerbates gut inflammation in salmonella typhimurium-infected gnotobiotic mice. PLoS One. 2013;8:e74963.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med. 2016;8:343ra82.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Ha S, Yeung E, Bell E, Insaf T, Ghassabian A, Bell G, et al. Prenatal and early life exposures to ambient air pollution and development. Environ Res. 2019;174:170–5.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Zheng J, Xiao X, Zhang Q, Wang T, Yu M, Xu J. Maternal low-protein diet modulates glucose metabolism and hepatic microRNAs expression in the early life of offspring †. Nutrients. 2017;9.

  38. 38.

    Alexander BT, Dasinger JH, Intapad S. Fetal programming and cardiovascular pathology. Compr Physiol. 2015;5:997–1025.

    Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Marques AH, O’Connor TG, Roth C, Susser E, Bjørke-Monsen A-L. The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders. Front Neurosci. 2013;7(7 JUL):120.

    Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Martínez I, Stegen JC, Maldonado-Gómez MX, Eren AM, Siba PM, Greenhill AR, et al. The gut microbiota of rural papua new guineans: composition, diversity patterns, and ecological processes. Cell Rep. 2015;11:527–38.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Sonnenburg ED, Sonnenburg JL. Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab. 2014;20:779–86.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG. 2016;123:983–93.

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Gera T, Shah D, Sachdev HS. Impact of water, sanitation and hygiene interventions on growth, non-diarrheal morbidity and mortality in children residing in low- and middle-income countries: a systematic review. Indian Pediatr. 2018;55:381–93.

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Vaz Nery S, Bennett I, Clarke NE, Lin A, Rahman Z, Rahman M, et al. Characterisation of environmental enteropathy biomarkers and associated risk factors in children in the context of a WASH trial in Timor-Leste. Int J Hyg Environ Health. 2018;221:901–6.

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    Velazquez S, Griffiths W, Dietz L, Horve P, Nunez S, Hu J, et al. From one species to another: A review on the interaction between chemistry and microbiology in relation to cleaning in the built environment. Indoor Air. 2019;29:880–94.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  46. 46.

    Tun MH, Tun HM, Mahoney JJ, Konya TB, Guttman DS, Becker AB, et al. Postnatal exposure to household disinfectants, infant gut microbiota and subsequent risk of overweight in children. CMAJ. 2018;190:E1341.

    Article  Google Scholar 

  47. 47.

    Forgie AJ, Fouhse JM, Willing BP. Diet-microbe-host interactions that affect gut mucosal integrity and infection resistance. Front Immunol. 2019;10(August):1802.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Semba RD. The rise and fall of protein malnutrition in global health. Ann Nutr Metab. 2016;69:79–88.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Henry CJ. What children eat in developing countries: diet in the etiology of undernutrition? Nestle Nutr Inst Workshop Ser. 2019;91:43–53.

    Article  PubMed  Google Scholar 

  50. 50.

    Pelletier DL, Frongillo EA, Habicht JP. Epidemiologic evidence for a potentiating effect of malnutrition on child mortality. Am J Public Health. 1993;83:1130–3.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Batool R, Butt MS, Sultan MT, Saeed F, Naz R. Protein-energy malnutrition: a risk factor for various ailments. Crit Rev Food Sci Nutr. 2015;55:242–53.

    Article  PubMed  Google Scholar 

  52. 52.

    Arsenault JE, Brown KH. Dietary protein intake in young children in selected low-income countries is generally adequate in relation to estimated requirements for healthy children, except when complementary food intake is low. J Nutr. 2017;147:932–9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  53. 53.

    Jahan-Mihan A, Luhovyy BL, El Khoury D, Anderson GH. Dietary proteins as determinants of metabolic and physiologic functions of the gastrointestinal tract. Nutrients. 2011;3:574–603.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  54. 54.

    Yao CK, Muir JG, Gibson PR. Review article: insights into colonic protein fermentation, its modulation and potential health implications. Aliment Pharmacol Ther. 2016;43:181–96.

    CAS  Article  PubMed  Google Scholar 

  55. 55.

    Diether NE, Willing BP. Microbial fermentation of dietary protein: an important factor in diet−microbe−host interaction. Microorganisms. 2019;7:19.

    CAS  Article  PubMed Central  Google Scholar 

  56. 56.

    Ghosh S, Suri D, Uauy R. Assessment of protein adequacy in developing countries: quality matters. Br J Nutr. 2012;108(Suppl):S77–87.

    CAS  Article  PubMed  Google Scholar 

  57. 57.

    Mayneris-Perxachs J, Bolick DT, Leng J, Medlock GL, Kolling GL, Papin JA, et al. Protein- and zinc-deficient diets modulate the murine microbiome and metabolic phenotype. Am J Clin Nutr. 2016;104:1253–62.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  58. 58.

    Forgie AJ, Gao Y, Ju T, Pepin DM, Yang K, Gänzle MG, et al. Pea polyphenolics and hydrolysis processing alter microbial community structure and early pathogen colonization in mice. J Nutr Biochem. 2019;67:101–10.

    CAS  Article  PubMed  Google Scholar 

  59. 59.

    Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470–81.

    CAS  Article  PubMed  Google Scholar 

  60. 60.

    Dalvi PS, Yang S, Swain N, Kim J, Saha S, Bourdon C, et al. Long-term metabolic effects of malnutrition: Liver steatosis and insulin resistance following early-life protein restriction. PLoS One. 2018;13:e0199916.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  61. 61.

    Martin LJ, Meng Q, Blencowe M, Lagarrigue S, Xiao S, Pan C, et al. Maternal high-protein and low-protein diets perturb hypothalamus and liver transcriptome and metabolic homeostasis in adult mouse offspring. Front Genet. 2018;9(December):642.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  62. 62.

    Deiuliis JA. MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes. 2016;40:88–101.

    CAS  Article  Google Scholar 

  63. 63.

    Tuchscherer M, Otten W, Kanitz E, Gräbner M, Tuchscherer A, Bellmann O, et al. Effects of inadequate maternal dietary protein:carbohydrate ratios during pregnancy on offspring immunity in pigs. BMC Vet Res. 2012;8:232.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  64. 64.

    Vanselow J, Kucia M, Langhammer M, Koczan D, Metges CC. Maternal high-protein diet during pregnancy, but not during suckling, induced altered expression of an increasing number of hepatic genes in adult mouse offspring. Eur J Nutr. 2016;55:917–30.

    CAS  Article  PubMed  Google Scholar 

  65. 65.

    Maurer AD, Reimer RA. Maternal consumption of high-prebiotic fibre or -protein diets during pregnancy and lactation differentially influences satiety hormones and expression of genes involved in glucose and lipid metabolism in offspring in rats. Br J Nutr. 2011;105:329–38.

    CAS  Article  PubMed  Google Scholar 

  66. 66.

    Carlin G, Chaumontet C, Blachier F, Barbillon P, Darcel N, Blais A, et al. Maternal high-protein diet during pregnancy modifies rat offspring body weight and insulin signalling but not macronutrient preference in adulthood. Nutrients. 2019;11:1–17.

    CAS  Article  Google Scholar 

  67. 67.

    Desclée de Maredsous C, Oozeer R, Barbillon P, Mary-Huard T, Delteil C, Blachier F, et al. High-protein exposure during gestation or lactation or after weaning has a period-specific signature on rat pup weight, adiposity, food intake, and glucose homeostasis up to 6 weeks of age. J Nutr. 2016;146:21–9.

    CAS  Article  PubMed  Google Scholar 

  68. 68.

    Koletzko B, von Kries R, Closa R, Monasterolo RC, Escribano J, Subías JE, et al. Can infant feeding choices modulate later obesity risk? Am J Clin Nutr. 2009;89:1502S–8S.

    CAS  Article  PubMed  Google Scholar 

  69. 69.

    Heinig MJ, Nommsen LA, Peerson JM, Lonnerdal B, Dewey KG. Energy and protein intakes of breast-fed and formula-fed infants during the first year of life and their association with growth velocity: the DARLING Study. Am J Clin Nutr. 1993;58:152–61.

    CAS  Article  PubMed  Google Scholar 

  70. 70.

    Martin CR, Ling P-R, Blackburn GL. Review of infant feeding: key features of breast milk and infant formula. Nutrients. 2016;8:1–11.

    CAS  Article  Google Scholar 

  71. 71.

    Weber M, Grote V, Closa-Monasterolo R, Escribano J, Langhendries J-P, Dain E, et al. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. Am J Clin Nutr. 2014;99:1041–51.

    CAS  Article  Google Scholar 

  72. 72.

    He X, Parenti M, Grip T, Domellöf M, Lönnerdal B, Hernell O, et al. Metabolic phenotype of breast-fed infants, and infants fed standard formula or bovine MFGM supplemented formula: a randomized controlled trial. Sci Rep. 2019;9:339.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  73. 73.

    He X, Parenti M, Grip T, Lönnerdal B, Timby N, Domellöf M, et al. Fecal microbiome and metabolome of infants fed bovine MFGM supplemented formula or standard formula with breast-fed infants as reference: a randomized controlled trial. Sci Rep. 2019;9:11589.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  74. 74.

    Kaimila Y, Divala O, Agapova SE, Stephenson KB, Thakwalakwa C, Trehan I, et al. Consumption of animal-source protein is associated with improved height-for-age z scores in rural Malawian children aged 12−36 months. Nutrients. 2019;11:1–21.

    CAS  Article  Google Scholar 

  75. 75.

    Nuss ET, Tanumihardjo SA. Quality protein maize for Africa: closing the protein inadequacy gap in vulnerable populations. Adv Nutr. 2011;2:217–24.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  76. 76.

    Etienne-Mesmin L, Chassaing B, Gewirtz AT. Tryptophan: a gut microbiota-derived metabolites regulating inflammation. World J Gastrointest Pharmacol Ther. 2017;8:7–9.

    Article  PubMed  PubMed Central  Google Scholar 

  77. 77.

    Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39:372–85.

    CAS  Article  PubMed  Google Scholar 

  78. 78.

    El-Zaatari M, Chang Y-M, Zhang M, Franz M, Shreiner A, McDermott AJ, et al. Tryptophan catabolism restricts IFN-γ-expressing neutrophils and clostridium difficile immunopathology. J Immunol. 2014;193:807–16.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  79. 79.

    Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487:477–81.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  80. 80.

    Jonkers DMAE. Microbial perturbations and modulation in conditions associated with malnutrition and malabsorption. Best Pract Res Clin Gastroenterol. 2016;30:161–72.

    CAS  Article  PubMed  Google Scholar 

  81. 81.

    Semova I, Carten JD, Stombaugh J, Mackey LC, Knight R, Farber SA, et al. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe. 2012;12:277–88.

    CAS  Article  PubMed  Google Scholar 

  82. 82.

    Owino V, Ahmed T, Freemark M, Kelly P, Loy A, Manary M, et al. Environmental enteric dysfunction and growth failure/stunting in global child health. Pediatrics. 2016;138.

  83. 83.

    Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A. 2011;108(Suppl SUPPL. 1):4523–30.

    Article  PubMed  Google Scholar 

  84. 84.

    Byrne CS, Chambers ES, Morrison DJ, Frost G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes. 2015;39:1331–8.

    CAS  Article  Google Scholar 

  85. 85.

    Krajmalnik-Brown R, Ilhan Z-E, Kang D-W, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract. 2012;27:201–14.

    Article  PubMed  PubMed Central  Google Scholar 

  86. 86.

    Chang EB, Martinez-Guryn K. Small intestinal microbiota: the neglected stepchild needed for fat digestion and absorption. Gut Microbes. 2019;10:235–40.

    Article  PubMed  Google Scholar 

  87. 87.

    Martinez-Guryn K, Hubert N, Frazier K, Urlass S, Musch MW, Ojeda P, et al. Small Intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids. Cell Host Microbe. 2018;23:458–469.e5.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  88. 88.

    Innis SM. Impact of maternal diet on human milk composition and neurological development of infants. Am J Clin Nutr. 2014;99:734S–41S.

    CAS  Article  PubMed  Google Scholar 

  89. 89.

    Richard C, Lewis ED, Field CJ. Evidence for the essentiality of arachidonic and docosahexaenoic acid in the postnatal maternal and infant diet for the development of the infant’s immune system early in life. Appl Physiol Nutr Metab. 2016;41:461–75.

    CAS  Article  PubMed  Google Scholar 

  90. 90.

    Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG, et al. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun. 2017;59:21–37.

    CAS  Article  PubMed  Google Scholar 

  91. 91.

    Patterson E, O’Doherty RM, Murphy EF, Wall R, O’Sullivan O, Nilaweera K, et al. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice. Br J Nutr. 2014;111:1905–17.

    CAS  Article  PubMed  Google Scholar 

  92. 92.

    Costantini L, Molinari R, Farinon B, Merendino N. Impact of omega-3 fatty acids on the gut microbiota. Int J Mol Sci. 2017;18.

  93. 93.

    Pusceddu MM, El Aidy S, Crispie F, O’Sullivan O, Cotter P, Stanton C, et al. N-3 polyunsaturated fatty acids (PUFAs) reverse the impact of earlylife stress on the gut microbiota. PLoS One. 2015;10:e0139721.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  94. 94.

    Wan J, Hu S, Jacoby JJ, Liu J, Zhang Y, Yu LL. The impact of dietary sn-2 palmitic triacylglycerols in combination with docosahexaenoic acid or arachidonic acid on lipid metabolism and host faecal microbiota composition in Sprague Dawley rats. Food Funct. 2017;8:1793–802.

    CAS  Article  PubMed  Google Scholar 

  95. 95.

    Lavallee CM, Lim DW, Wizzard PR, Mazurak VC, Mi S, Curtis JM, et al. Impact of clinical use of parenteral lipid emulsions on bile acid metabolism and composition in neonatal piglets. JPEN J Parenter Enteral Nutr. 2019;43:668–76.

    CAS  Article  PubMed  Google Scholar 

  96. 96.

    Younge NE, Newgard CB, Cotten CM, Goldberg RN, Muehlbauer MJ, Bain JR, et al. Disrupted maturation of the microbiota and metabolome among extremely preterm infants with postnatal growth failure. Sci Rep. 2019;9:8167.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  97. 97.

    Kanter M. High-quality carbohydrates and physical performance: expert panel report. Nutr Today. 2018;53:35–9.

    Article  PubMed  Google Scholar 

  98. 98.

    Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013;36:587–97.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  99. 99.

    Westman EC. Is dietary carbohydrate essential for human nutrition? Am J Clin Nutr. 2002;75:951–3; author reply 953-4.

    CAS  Article  PubMed  Google Scholar 

  100. 100.

    Ludwig DS, Hu FB, Tappy L, Brand-Miller J. Dietary carbohydrates: role of quality and quantity in chronic disease. BMJ. 2018;361:k2340.

    Article  PubMed  PubMed Central  Google Scholar 

  101. 101.

    Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol. 1991;70:443–59.

    CAS  Article  PubMed  Google Scholar 

  102. 102.

    Omer A, Quigley EMM. Carbohydrate maldigestion and malabsorption. Clin Gastroenterol Hepatol. 2018;16:1197–9.

    Article  PubMed  Google Scholar 

  103. 103.

    Kvissberg MA, Dalvi PS, Kerac M, Voskuijl W, Berkley JA, Priebe MG, et al. Carbohydrate malabsorption in acutely malnourished children and infants: a systematic review. Nutr Rev. 2016;74:48–58.

    Article  PubMed  Google Scholar 

  104. 104.

    DiNicolantonio JJ, O’Keefe J. Markedly increased intake of refined carbohydrates and sugar is associated with the rise of coronary heart disease and diabetes among the Alaskan Inuit. Open Hear. 2017;4:e000673.

    Article  Google Scholar 

  105. 105.

    DiNicolantonio JJ. Increase in the intake of refined carbohydrates and sugar may have led to the health decline of the Greenland Eskimos. Open Hear. 2016;3:e000444.

    Article  Google Scholar 

  106. 106.

    Li J-M, Yu R, Zhang L-P, Wen S-Y, Wang S-J, Zhang X-Y, et al. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids. Microbiome. 2019;7:98.

    Article  PubMed  PubMed Central  Google Scholar 

  107. 107.

    Laffin M, Fedorak R, Zalasky A, Park H, Gill A, Agrawal A, et al. A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice. Sci Rep. 2019;9:12294.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  108. 108.

    Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and metaanalyses. Lancet (London, England). 2019;393:434–45.

    CAS  Article  Google Scholar 

  109. 109.

    Makki K, Deehan EC, Walter J, Bäckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23:705–15.

    CAS  Article  PubMed  Google Scholar 

  110. 110.

    Dahl WJ, Stewart ML. Position of the academy of nutrition and dietetics: health implications of dietary fiber. J Acad Nutr Diet. 2015;115:1861–70.

    Article  PubMed  Google Scholar 

  111. 111.

    Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5:1417–35.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  112. 112.

    Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer R-J. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104–19.

    CAS  Article  PubMed  Google Scholar 

  113. 113.

    Litvak Y, Byndloss MX, Bäumler AJ. Colonocyte metabolism shapes the gut microbiota. Science. 2018;362.

  114. 114.

    Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17:662–71.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  115. 115.

    Louis NA, Hamilton KE, Canny G, Shekels LL, Ho SB, Colgan SP. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J Cell Biochem. 2006;99:1616–27.

    CAS  Article  PubMed  Google Scholar 

  116. 116.

    Kelly CJ, Glover LE, Campbell EL, Kominsky DJ, Ehrentraut SF, Bowers BE, et al. Fundamental role for HIF-1α in constitutive expression of human β defensin-1. Mucosal Immunol. 2013;6:1110–8.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  117. 117.

    Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, et al. Microbiota-accessible carbohydrates suppress clostridium difficile infection in a murine model. Nat Microbiol. 2018;3:662–9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  118. 118.

    Daïen CI, Pinget GV, Tan JK, Macia L. Detrimental impact of microbiota-accessible carbohydrate-deprived diet on gut and immune homeostasis: an overview. Front Immunol. 2017;8(MAY):548.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  119. 119.

    Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:718–27.

    CAS  Article  PubMed  Google Scholar 

  120. 120.

    UNICEF & United Nations University & World Health Organization. Iron deficiency anaemia: assessment, prevention, and control : a guide for programme managers. Geneva: WHO; 2001.

    Google Scholar 

  121. 121.

    WHO. The global prevalence of anaemia in 2011. Geneva: World Heal Organ; 2015.

    Google Scholar 

  122. 122.

    Lozoff B, Jimenez E, Smith JB. Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years. Arch Pediatr Adolesc Med. 2006;160:1108–13.

    Article  PubMed  PubMed Central  Google Scholar 

  123. 123.

    Lukowski AF, Koss M, Burden MJ, Jonides J, Nelson CA, Kaciroti N, et al. Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory. Nutr Neurosci. 2010;13:54–70.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  124. 124.

    Congdon EL, Westerlund A, Algarin CR, Peirano PD, Gregas M, Lozoff B, et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr. 2012;160:1027–33.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  125. 125.

    Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev. 2006;64(5 Pt 2):S34–43; discussion S72-91.

    Article  PubMed  PubMed Central  Google Scholar 

  126. 126.

    Georgieff MK. Long-term brain and behavioral consequences of early iron deficiency. Nutr Rev. 2011;69(Suppl 1):S43–8.

    Article  PubMed  PubMed Central  Google Scholar 

  127. 127.

    Gambling L, Dunford S, Wallace DI, Zuur G, Solanky N, Srai SKS, et al. Iron deficiency during pregnancy affects postnatal blood pressure in the rat. J Physiol. 2003;552(Pt 2):603–10.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  128. 128.

    Lisle SJM, Lewis RM, Petry CJ, Ozanne SE, Hales CN, Forhead AJ. Effect of maternal iron restriction during pregnancy on renal morphology in the adult rat offspring. Br J Nutr. 2003;90:33–9.

    CAS  Article  PubMed  Google Scholar 

  129. 129.

    Lewis RM, Petry CJ, Ozanne SE, Hales CN. Effects of maternal iron restriction in the rat on blood pressure, glucose tolerance, and serum lipids in the 3-month-old offspring. Metabolism. 2001;50:562–7.

    CAS  Article  PubMed  Google Scholar 

  130. 130.

    Bourque SL, Komolova M, McCabe K, Adams MA, Nakatsu K. Perinatal iron deficiency combined with a high-fat diet causes obesity and cardiovascular dysregulation. Endocrinology. 2012;153:1174–82.

    CAS  Article  PubMed  Google Scholar 

  131. 131.

    Woodman AG, Mah R, Keddie DL, Noble RMN, Holody CD, Panahi S, et al. Perinatal iron deficiency and a high salt diet cause long-term kidney mitochondrial dysfunction and oxidative stress. Cardiovasc Res. 2019;32:3254–63.

    Article  Google Scholar 

  132. 132.

    Woodman AG, Care AS, Mansour Y, Cherak SJ, Panahi S, Gragasin FS, et al. Modest and severe maternal iron deficiency in pregnancy are associated with fetal anaemia and organ-specific hypoxia in rats. Sci Rep. 2017;7(April):46573.

    Article  PubMed  PubMed Central  Google Scholar 

  133. 133.

    Woodman AG, Mah R, Keddie D, Noble RMN, Panahi S, Gragasin FS, et al. Prenatal iron deficiency causes sex-dependent mitochondrial dysfunction and oxidative stress in fetal rat kidneys and liver. FASEB J. 2018;32:3254–63.

    CAS  Article  PubMed  Google Scholar 

  134. 134.

    Lien Y-C, Condon DE, Georgieff MK, Simmons RA, Tran PV. Dysregulation of neuronal genes by fetal-neonatal iron deficiency anemia is associated with altered DNA methylation in the rat hippocampus. Nutrients. 2019;11.

  135. 135.

    Schachtschneider KM, Liu Y, Rund LA, Madsen O, Johnson RW, Groenen MAM, et al. Impact of neonatal iron deficiency on hippocampal DNA methylation and gene transcription in a porcine biomedical model of cognitive development. BMC Genomics. 2016;17:856.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  136. 136.

    Bastian TW, Prohaska JR, Georgieff MK, Anderson GW. Perinatal iron and copper deficiencies alter neonatal rat circulating and brain thyroid hormone concentrations. Endocrinology. 2010;151:4055–65.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  137. 137.

    Felt BT, Beard JL, Schallert T, Shao J, Aldridge JW, Connor JR, et al. Persistent neurochemical and behavioral abnormalities in adulthood despite early iron supplementation for perinatal iron deficiency anemia in rats. Behav Brain Res. 2006;171:261–70.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  138. 138.

    Felt BT, Peirano P, Algarín C, Chamorro R, Sir T, Kaciroti N, et al. Long-term neuroendocrine effects of iron-deficiency anemia in infancy. Pediatr Res. 2012;71:707–12.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  139. 139.

    Dostal A, Lacroix C, Bircher L, Pham VT, Follador R, Zimmermann MB, et al. Iron modulates butyrate production by a child gut microbiota in vitro. MBio. 2015;6:e01453–15.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  140. 140.

    Dostal A, Fehlbaum S, Chassard C, Zimmermann MB, Lacroix C. Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. FEMS Microbiol Ecol. 2013;83:161–75.

    CAS  Article  PubMed  Google Scholar 

  141. 141.

    Andrews SC, Robinson AK, Rodríguez-Quiñones F. Bacterial iron homeostasis. FEMS Microbiol Rev. 2003;27:215–37.

    CAS  Article  PubMed  Google Scholar 

  142. 142.

    Naikare H, Palyada K, Panciera R, Marlow D, Stintzi A. Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect Immun. 2006;74:5433–44.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  143. 143.

    Bullen J, Griffiths E, Rogers H, Ward G. Sepsis: the critical role of iron. Microbes Infect. 2000;2:409–15.

    CAS  Article  PubMed  Google Scholar 

  144. 144.

    Muleviciene A, D’Amico F, Turroni S, Candela M, Jankauskiene A. Iron deficiency anemia-related gut microbiota dysbiosis in infants and young children: a pilot study. Acta Microbiol Immunol Hung. 2018;65:551–64.

    CAS  Article  PubMed  Google Scholar 

  145. 145.

    McClorry S, Zavaleta N, Llanos A, Casapía M, Lönnerdal B, Slupsky CM. Anemia in infancy is associated with alterations in systemic metabolism and microbial structure and function in a sex-specific manner: an observational study. Am J Clin Nutr. 2018;108:1238–48.

    Article  PubMed  PubMed Central  Google Scholar 

  146. 146.

    Dostal A, Chassard C, Hilty FM, Zimmermann MB, Jaeggi T, Rossi S, et al. Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats. J Nutr. 2012;142:271–7.

    CAS  Article  PubMed  Google Scholar 

  147. 147.

    Dostal A, Baumgartner J, Riesen N, Chassard C, Smuts CM, Zimmermann MB, et al. Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation: a randomised, placebo-controlled intervention trial in South African children. Br J Nutr. 2014;112:547–56.

    CAS  Article  PubMed  Google Scholar 

  148. 148.

    Paganini D, Zimmermann MB. The effects of iron fortification and supplementation on the gut microbiome and diarrhea in infants and children: a review. Am J Clin Nutr. 2017;106(Suppl 6):1688S–93S.

    Article  PubMed  PubMed Central  Google Scholar 

  149. 149.

    Kortman GAM, Raffatellu M, Swinkels DW, Tjalsma H. Nutritional iron turned inside out: intestinal stress from a gut microbial perspective. FEMS Microbiol Rev. 2014;38:1202–34.

    CAS  Article  PubMed  Google Scholar 

  150. 150.

    Yilmaz B, Li H. Gut microbiota and iron: the crucial actors in health and disease. Pharmaceuticals (Basel). 2018;11:1–20.

    CAS  Article  Google Scholar 

  151. 151.

    Lopez CA, Skaar EP. The impact of dietary transition metals on host-bacterial interactions. Cell Host Microbe. 2018;23:737–48.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  152. 152.

    Zimmermann MB, Chassard C, Rohner F, N’goran EK, Nindjin C, Dostal A, et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d’Ivoire. Am J Clin Nutr. 2010;92:1406–15.

    CAS  Article  PubMed  Google Scholar 

  153. 153.

    Jaeggi T, Kortman GAM, Moretti D, Chassard C, Holding P, Dostal A, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64:731–42.

    CAS  Article  PubMed  Google Scholar 

  154. 154.

    Tang M, Frank DN, Hendricks AE, Ir D, Esamai F, Liechty E, et al. Iron in micronutrient powder promotes an unfavorable gut microbiota in Kenyan infants. Nutrients. 2017;9:1–12.

    CAS  Article  Google Scholar 

  155. 155.

    Prentice AM, Mendoza YA, Pereira D, Cerami C, Wegmuller R, Constable A, et al. Dietary strategies for improving iron status: balancing safety and efficacy. Nutr Rev. 2017;75:49–60.

    Article  PubMed  Google Scholar 

  156. 156.

    Mokhtar RR, Holick MF, Sempértegui F, Griffiths JK, Estrella B, Moore LL, et al. Vitamin D status is associated with underweight and stunting in children aged 6-36 months residing in the Ecuadorian Andes. Public Health Nutr. 2018;21:1974–85.

    Article  PubMed  Google Scholar 

  157. 157.

    Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004;29:664–73.

    CAS  Article  PubMed  Google Scholar 

  158. 158.

    Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-κB activity in intestine. Am J Pathol. 2010;177:686–97.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  159. 159.

    Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010;26:591–5.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  160. 160.

    Kozyrskyj AL, Tun HM, Bridgman SL. The gut microbiome and control of weight gain. In: M. F, editor. Contemporary endocrinology. Cham: Pediatric. Humana Press; 2018. p. 63–78.

    Google Scholar 

  161. 161.

    Waterhouse M, Hope B, Krause L, Morrison M, Protani MM, Zakrzewski M, et al. Vitamin D and the gut microbiome: a systematic review of in vivo studies. Eur J Nutr. 2018;0:0.

    CAS  Article  Google Scholar 

  162. 162.

    Ooi JH, Chen J, Cantorna MT. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol Asp Med. 2012;33:77–82.

    CAS  Article  Google Scholar 

  163. 163.

    Jin D, Wu S, Zhang Y-G, Lu R, Xia Y, Dong H, et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther. 2015;37:996–1009.e7.

    CAS  Article  PubMed  Google Scholar 

  164. 164.

    Luthold RV, Fernandes GR, Franco-de-Moraes AC, Folchetti LGD, Ferreira SRG. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals. Metabolism. 2017;69:76–86.

    CAS  Article  PubMed  Google Scholar 

  165. 165.

    Bashir M, Prietl B, Tauschmann M, Mautner SI, Kump PK, Treiber G, et al. Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr. 2016;55:1479–89.

    CAS  Article  PubMed  Google Scholar 

  166. 166.

    Quraishi SA, Litonjua AA, Moromizato T, Gibbons FK, Camargo CA, Giovannucci E, et al. Association between prehospital vitamin D status and hospital-acquired clostridium difficile infections. JPEN J Parenter Enteral Nutr. 2015;39:47–55.

    CAS  Article  PubMed  Google Scholar 

  167. 167.

    Talsness CE, Penders J, Jansen EHJM, Damoiseaux J, Thijs C, Mommers M. Influence of vitamin D on key bacterial taxa in infant microbiota in the KOALA Birth Cohort Study. PLoS One. 2017;12:e0188011.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  168. 168.

    Sordillo JE, Zhou Y, McGeachie MJ, Ziniti J, Lange N, Laranjo N, et al. Factors influencing the infant gut microbiome at age 3-6 months: findings from the ethnically diverse Vitamin D Antenatal Asthma Reduction Trial (VDAART). J Allergy Clin Immunol. 2017;139:482–491.e14.

    Article  PubMed  Google Scholar 

  169. 169.

    Clark A, Mach N. Role of vitamin D in the hygiene hypothesis: the interplay between vitamin D, vitamin D receptors, gut microbiota, and immune response. Front Immunol. 2016;7(DEC):627.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  170. 170.

    Margulies SL, Kurian D, Elliott MS, Han Z. Vitamin D deficiency in patients with intestinal malabsorption syndromes--think in and outside the gut. J Dig Dis. 2015;16:617–33.

    CAS  Article  PubMed  Google Scholar 

  171. 171.

    O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010;2:299–316.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  172. 172.

    Wolffenbuttel BHR, Wouters HJCM, Heiner-Fokkema MR, van der Klauw MM. The many faces of cobalamin (Vitamin B12) deficiency. Mayo Clin proceedings Innov Qual outcomes. 2019;3:200–14.

    Article  Google Scholar 

  173. 173.

    Goyal S, Tiwari K, Meena P, Malviya S, Asif M. Cobalamin and folate status in malnourished children. Int J Contemp Pediatr. 2017;4:1480.

    Article  Google Scholar 

  174. 174.

    Yaikhomba T, Poswal L, Goyal S. Assessment of iron, folate and vitamin B12 status in severe acute malnutrition. Indian J Pediatr. 2015;82:511–4.

    Article  PubMed  Google Scholar 

  175. 175.

    Kvestad I, Hysing M, Shrestha M, Ulak M, Thorne-Lyman AL, Henjum S, et al. Vitamin B-12 status in infancy is positively associated with development and cognitive functioning 5 y later in Nepalese children. Am J Clin Nutr. 2017;105:1122–31.

    CAS  Article  PubMed  Google Scholar 

  176. 176.

    Demir N, Koc A, Üstyol L, Peker E, Abuhandan M. Clinical and neurological findings of severe vitamin B12 deficiency in infancy and importance of early diagnosis and treatment. J Paediatr Child Health. 2013;49:820–4.

    Article  PubMed  Google Scholar 

  177. 177.

    Roman-Garcia P, Quiros-Gonzalez I, Mottram L, Lieben L, Sharan K, Wangwiwatsin A, et al. Vitamin B12-dependent taurine synthesis regulates growth and bone mass. J Clin Invest. 2014;124:2988–3002.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  178. 178.

    Degnan PH, Barry NA, Mok KC, Taga ME, Goodman AL. Human gut microbes use multiple transporters to distinguish vitamin B12 analogs and compete in the gut. Cell Host Microbe. 2014;15:47–57.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  179. 179.

    Allen RH, Stabler SP. Identification and quantitation of cobalamin and cobalamin analogues in human feces. Am J Clin Nutr. 2008;87:1324–35.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  180. 180.

    Degnan PH, Taga ME, Goodman AL. Vitamin B12 as a modulator of gut microbial ecology. Cell Metab. 2014;20:769–78.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  181. 181.

    Belzer C, Chia LW, Aalvink S, Chamlagain B, Piironen V, Knol J, et al. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. MBio. 2017;8:1–14.

    Article  Google Scholar 

  182. 182.

    Fischbach MA, Sonnenburg JL. Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe. 2011;10:336–47.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  183. 183.

    Wexler AG, Schofield WB, Degnan PH, Folta-Stogniew E, Barry NA, Goodman AL. Human gut Bacteroides capture vitamin B12 via cell surfaceexposed lipoproteins. Elife. 2018;7:1–20.

    Article  Google Scholar 

  184. 184.

    Cordonnier C, Le Bihan G, Emond-Rheault J-G, Garrivier A, Harel J, Jubelin G. Vitamin B12 uptake by the gut commensal bacteria bacteroides thetaiotaomicron limits the production of shiga toxin by enterohemorrhagic escherichia coli. Toxins (Basel). 2016;8:14.

    CAS  Article  Google Scholar 

Download references


Not applicable.


Not applicable.

Availability of data and materials

Not applicable.

Author information




AJF conceived, edited, and wrote the manuscript. BPW conceived and edited the manuscript. ALK and KMD wrote the hygiene and vitamin D section. CJF wrote the fat section. SLB wrote the iron section. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Benjamin P. Willing.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Forgie, A.J., Drall, K.M., Bourque, S.L. et al. The impact of maternal and early life malnutrition on health: a diet-microbe perspective. BMC Med 18, 135 (2020).

Download citation


  • Undernutrition
  • Malnutrition
  • Diet
  • Microbiome
  • Gastrointestinal
  • Disease
  • Health